» Articles » PMID: 30303384

G-Quadruplex-Based Nanoscale Coordination Polymers to Modulate Tumor Hypoxia and Achieve Nuclear-Targeted Drug Delivery for Enhanced Photodynamic Therapy

Overview
Journal Nano Lett
Specialty Biotechnology
Date 2018 Oct 11
PMID 30303384
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Photodynamic therapy (PDT) is a light-triggered therapy used to kill cancer cells by producing reactive oxygen species (ROS). Herein, a new kind of DNA nanostructure based on the coordination between calcium ions (Ca) and AS1411 DNA G quadruplexes to form nanoscale coordination polymers (NCPs) is developed via a simple method. Both chlorine e6 (Ce6), a photosensitizer, and hemin, an iron-containing porphyrin, can be inserted into the G-quadruplex structure in the obtained NCPs. With further polyethylene glycol (PEG) modification, we obtain Ca-AS1411/Ce6/hemin@pHis-PEG (CACH-PEG) NCP nanostructure that enables the intranuclear transport of photosensitizer Ce6 to generate ROS inside cell nuclei that are the most vulnerable to ROS. Meanwhile, the inhibition of antiapoptotic protein B-cell lymphoma 2 (Bcl-2) expression by AS1411 allows for greatly improved PDT-induced cell apoptosis. Furthermore, the catalase-mimicking DNAzyme function of G-quadruplexes and hemin in those NCPs could decompose tumor endogenous HO to in situ generate oxygen so as to further enhance PDT by overcoming the hypoxia-associated resistance. This work develops a simple yet general method with which to fabricate DNA-based NCPs and presents an interesting concept of a nanoscale drug-delivery system that could achieve the intranuclear delivery of photosensitizers, the down-regulation of anti-apoptotic proteins, and the modulation of the unfavorable tumor microenvironment simultaneously for improved cancer therapy.

Citing Articles

Light-based technologies in immunotherapy: advances, mechanisms and applications.

Frumento D, talu S Immunotherapy. 2025; 17(2):123-131.

PMID: 40032620 PMC: 11901425. DOI: 10.1080/1750743X.2025.2470111.


Novel photodynamic therapy using two-dimensional NiPS nanosheets that target hypoxic microenvironments for precise cancer treatment.

Wu Z, Liu Q, Wageh S, Sun Z, Al-Hartomy O, Al-Sehemi A Nanophotonics. 2024; 12(1):81-98.

PMID: 39633642 PMC: 11501689. DOI: 10.1515/nanoph-2022-0520.


An intelligent poly aptamer-encoded DNA nanoclew for tumor site activated mitochondria-targeted photodynamic therapy and MR imaging.

Chen M, Xu H, Chang P, Li X, Liu S, Xu L Mater Today Bio. 2024; 29:101318.

PMID: 39534680 PMC: 11554627. DOI: 10.1016/j.mtbio.2024.101318.


Transformable self-delivered supramolecular nanomaterials combined with anti-PD-1 antibodies alleviate tumor immunosuppression to treat breast cancer with bone metastasis.

Liu X, Wang H, Li Z, Li J, He S, Hu C J Nanobiotechnology. 2024; 22(1):566.

PMID: 39272206 PMC: 11401275. DOI: 10.1186/s12951-024-02839-0.


Engineered photoresponsive biohybrids for tumor therapy.

Wang X, Sun Y, Wangpraseurt D Smart Med. 2024; 2(2):e20220041.

PMID: 39188274 PMC: 11235730. DOI: 10.1002/SMMD.20220041.